BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 26482315)

  • 1. Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection.
    Falcone M; Russo A; Iraci F; Carfagna P; Goldoni P; Vullo V; Venditti M
    Antimicrob Agents Chemother; 2016 Jan; 60(1):252-7. PubMed ID: 26482315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and risk factors for mortality in bloodstream infection by CP-Kp, ESBL-E, Candida and CDI: A single center retrospective study.
    Corcione S; Angilletta R; Raviolo S; Filippini C; Fossati L; Di Perri G; Cavallo R; De Rosa FG
    Eur J Intern Med; 2018 Feb; 48():44-49. PubMed ID: 29096992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Clostridium difficile infection a risk factor for subsequent bloodstream infection?
    Ulrich RJ; Santhosh K; Mogle JA; Young VB; Rao K
    Anaerobe; 2017 Dec; 48():27-33. PubMed ID: 28669864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious Complications in Severe Acute Pancreatitis: Pathogens, Drug Resistance, and Status of Nosocomial Infection in a University-Affiliated Teaching Hospital.
    Tian H; Chen L; Wu X; Li F; Ma Y; Cai Y; Song S
    Dig Dis Sci; 2020 Jul; 65(7):2079-2088. PubMed ID: 31691173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections.
    Seddon MM; Bookstaver PB; Justo JA; Kohn J; Rac H; Haggard E; Mediwala KN; Dash S; Al-Hasan MN
    Clin Infect Dis; 2019 Jul; 69(3):414-420. PubMed ID: 30312362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New and emerging therapies in treatment of Clostridium difficile infection.
    Goyal H; Perisetti A; Rehman MR; Singla U
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):589-597. PubMed ID: 29521664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 14-Year Survey in a Swedish County Reveals a Pronounced Increase in Bloodstream Infections (BSI). Comorbidity - An Independent Risk Factor for Both BSI and Mortality.
    Holmbom M; Giske CG; Fredrikson M; Östholm Balkhed Å; Claesson C; Nilsson LE; Hoffmann M; Hanberger H
    PLoS One; 2016; 11(11):e0166527. PubMed ID: 27835663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?
    Robin C; Héquette-Ruz R; Guery B; Boyle E; Herbaux C; Galperine T
    Med Mal Infect; 2017 Dec; 47(8):532-539. PubMed ID: 28823390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and clinical features of Clostridium difficile infection in Korea: a nationwide study.
    Kim YS; Han DS; Kim YH; Kim WH; Kim JS; Kim HS; Kim HS; Park YS; Song HJ; Shin SJ; Yang SK; Ye BD; Eun CS; Lee KM; Lee SH; Jang BI; Jung SA; Cheon JH; Choi CH; Huh KC
    Epidemiol Infect; 2013 Jan; 141(1):189-94. PubMed ID: 22717061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and risk factors for community-acquired Clostridium difficile infection: A retrospective, case-control study in a tertiary care hospital in Japan.
    Mori N; Aoki Y
    J Infect Chemother; 2015 Dec; 21(12):864-7. PubMed ID: 26482373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
    Tumbarello M; Sanguinetti M; Montuori E; Trecarichi EM; Posteraro B; Fiori B; Citton R; D'Inzeo T; Fadda G; Cauda R; Spanu T
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1987-94. PubMed ID: 17387156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
    Kimura T; Snijder R; Sugitani T
    J Infect Chemother; 2019 Aug; 25(8):615-620. PubMed ID: 30987950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and outcomes of Clostridium difficile infection in hospitalized patients.
    Lee HY; Hsiao HL; Chia CY; Cheng CW; Tsai TC; Deng ST; Chen CL; Chiu CH
    Biomed J; 2019 Apr; 42(2):99-106. PubMed ID: 31130254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The outcome of patients with severe and severe-complicated Clostridium difficile infection treated with tigecycline combination therapy: a retrospective observational study.
    Bishop EJ; Tiruvoipati R; Metcalfe J; Marshall C; Botha J; Kelley PG
    Intern Med J; 2018 Jun; 48(6):651-660. PubMed ID: 29363242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes.
    Falcone M; Tiseo G; Iraci F; Raponi G; Goldoni P; Delle Rose D; Santino I; Carfagna P; Murri R; Fantoni M; Fontana C; Sanguinetti M; Farcomeni A; Antonelli G; Aceti A; Mastroianni C; Andreoni M; Cauda R; Petrosillo N; Venditti M
    Clin Microbiol Infect; 2019 Apr; 25(4):474-480. PubMed ID: 29964230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enteropathogenetic nosocomial infections: predisposing clinical characteristics and risk of recurrent infections.
    Corcione S; Segala FV; Castiglione A; Lupia T; Angilletta R; Cavallo R; Ciccone G; De Rosa FG
    J Chemother; 2019; 31(7-8):394-400. PubMed ID: 31556352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe community onset healthcare-associated Clostridium difficile infection complicated by carbapenemase producing Klebsiella pneumoniae bloodstream infection.
    Giuliano S; Guastalegname M; Jenco M; Morelli A; Falcone M; Venditti M
    BMC Infect Dis; 2014 Sep; 14():475. PubMed ID: 25178451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection.
    Nerandzic MM; Mullane K; Miller MA; Babakhani F; Donskey CJ
    Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S121-6. PubMed ID: 22752860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027.
    Kamboj M; Xiao K; Kaltsas A; Huang YT; Sun J; Chung D; Wu S; Sheahan A; Sepkowitz K; Jakubowski AA; Papanicolaou G
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1626-33. PubMed ID: 24973628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early alert from the microbiology laboratory improves the outcome of elderly patients with Enterococcus spp. bloodstream infection: Results from a multicentre prospective study.
    Falcone M; Tiseo G; Dentali F; Foglia E; Campanini M; Menichetti F; Mazzone A;
    J Glob Antimicrob Resist; 2019 Sep; 18():139-144. PubMed ID: 30825701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.